7498 Results (Page 283 of 300)
Pharmaceuticals Markets Research Reports
Vietnam Central Nervous System (CNS) Therapeutics Market Analysis
The Vietnam Central Nervous System (CNS)Therapeutics Market was valued at $1.050 Bn in 2022 and is predicted to grow at a CAGR of 6.63% from 2023 to 2030, to $1.755 Bn by 2030. The key drivers of this industry include the rising burden of CNS disorders, targeted healthcare programs, and improved healthcare infrastructure. The industry is primarily dominated by players such as AbbVie, Novartis, Merck, AstraZeneca, Teva, and Eli Lilly among others.
Brazil Lipid Disorder Therapeutics Market Analysis
The Brazil Lipid Disorder Therapeutics Market was valued at $627.8 Mn in 2023 and is predicted to grow at a CAGR of 13.13% from 2023 to 2030, to $1,488.9 Mn by 2030. Brazil Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Cardiovascular Diseases, the ageing population, and Advancements in Therapeutics and Technologies. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd. Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Vietnam Chronic Pain Therapeutics Market Analysis
The Vietnam Chronic Pain Therapeutics Market is anticipated to experience a growth from $372 Mn in 2022 to $598 Mn by 2030, with a CAGR of 6.13% during the forecast period of 2022-2030. The key drivers include the rapidly aging population with an increased prevalence of age-related conditions, the growing demand for alternative treatments due to awareness of traditional medication side effects, and government initiatives aimed at improving access to pain specialists and therapies. The Vietnam Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Sanofi, Roche, Merck, Bayer, Traphaco, Mekophar, Imexpharm, DHG Pharmaceuticals, etc, among various others.
Canada Lipid Disorder Therapeutics Market Analysis
The Canada Lipid Disorder Therapeutics Market was valued at $808 Mn in 2023 and is predicted to grow at a CAGR of 12.63% from 2023 to 2030, to $1,857.8 Mn by 2030. Canada Lipid Disorder Therapeutics Market is growing due to an Increase in the Level of Triglyceride, Advancements in Therapeutics, and Growing Healthcare Expenditure, and Infrastructure. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Brazil Chronic Pain Therapeutics Market Analysis
The Brazil Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.858 Bn in 2022 to $3.168 Bn by 2030, with a CAGR of 6.9% during the forecast period of 2022-2030. The drivers of the Brazil Chronic Pain Therapeutics Market include the increasing incidence among the population owing to changing urban lifestyles, continuous advancements in pain management treatments, and crucial regulatory support and healthcare policies implemented by the Brazilian government. The Brazil Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Novartis, Merck, GSK, Sanofi, Roche, Hypera Pharma, EMS, Biolab Pharma, etc., among various others.
China Lipid Disorder Therapeutics Market Analysis
The China Lipid Disorder Therapeutics Market was valued at $262.6 Mn in 2023 and is predicted to grow at a CAGR of 10.63% from 2023 to 2030, to $532.6 Mn by 2030. China Lipid Disorder Therapeutics Market is growing due to Increasing Healthcare Expenditure, Rising Prevalence of Dyslipidemia, and Expanding Treatment Guidelines. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd.Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Canada Chronic Pain Therapeutics Market Analysis
The Canada Chronic Pain Therapeutics Market is anticipated to experience growth from $5.944 Bn in 2022 to $9.403 Bn by 2030, with a CAGR of 5.9% during the forecast period of 2022-2030. The significant aging of the population contributing to an increase in chronic conditions, the rise in chronic disease burdens such as diabetes and cancer due to lifestyle factors, and ongoing advancements in pain management therapeutics are all key market drivers, necessitating innovative solutions to meet patients' changing needs. The Canada Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, Medtronic, Pfizer, Sanofi, Cipher Pharmaceuticals, Pac Therapeutics, Paladin Labs, etc., among various others.
France Lipid Disorder Therapeutics Market Analysis
The France Lipid Disorder Therapeutics Market was valued at $50.50 Mn in 2023 and is predicted to grow at a CAGR of 12.86% from 2023 to 2030, to $117.78 Mn by 2030. France Lipid Disorder Therapeutics Market is growing due to Escalating Burden of Cardiovascular Disease, Demographic Shift, and Public Awareness. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., AbbVie, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Egypt Chronic Pain Therapeutics Market Analysis
The Egypt Chronic Pain Therapeutics Market is anticipated to experience a growth from $208 Mn in 2022 to $368 Mn by 2030, with a CAGR of 7.4% during the forecast period of 2022-2030. The key drivers include the rising prevalence of age-related chronic conditions, a growing healthcare expenditure, and a rising awareness leading to a demand for alternative and safer pain management options. The Egypt Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Sanofi, Roche, Merck, Abbott, AstraZeneca, EVA Pharma, Pharco, EIPICO, etc., among various others.
Indonesia Chronic Pain Therapeutics Market Analysis
The Indonesia Chronic Pain Therapeutics Market is anticipated to experience a growth from $446 Mn in 2022 to $705 Mn by 2030, with a CAGR of 5.9% during the forecast period of 2022-2030. An aging population with rising chronic pain, growing awareness among healthcare professionals and patients, and supportive government initiatives are the key drivers of this market. The Indonesia Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, Abbott, AstraZeneca, Bristol Myers Squibb, Roche, Johnson & Johnson, Kalbe Pharma, Indo Pharma, Kimia Pharma, Tempo Scan Group, etc., among various others.
Canada Dental Fluoride Treatment Market Analysis
The Canada Dental Fluoride Treatment Market was valued at $1,213.4 Mn in 2023 and is projected to grow at a CAGR of 3.9% from 2023 to 2023, to $1,586 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Colgate, 3M, Dentsply Sirona, VOCO, DÜRRDENTAL among others.
Japan Chronic Pain Therapeutics Market Analysis
The Japan Chronic Pain Therapeutics Market is anticipated to experience a growth from $4.618 Bn in 2022 to $7.586 Bn by 2030, with a CAGR of 6.4% during the forecast period of 2022-2030. The market is primarily driven by the rapidly aging population leading to an increased prevalence of chronic pain conditions, augmented healthcare expenditure, government support prioritizing pain management accessibility, and a growing demand for non-opioid alternatives. The Japan Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AstraZeneca, Sanofi, Merck, Roche, AbbVie, Astellas, Chugai Pharmaceuticals, Daiichi Sankyo, Eisai, etc., among various others.
US Dental Fluoride Treatment Market Analysis
The US Dental Fluoride Treatment Market was valued at $6,370.2 Mn in 2023 and is projected to grow at a CAGR of 1.9% from 2023 to 2023, to $7,267.3 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Procter & Gamble, Colgate Palmolive, Unilever, 3M and Ultradent Products among others.
Saudi Arabia Dental Fluoride Treatment Market Analysis
The Saudi Arabia Dental Fluoride Treatment Market was valued at $257.8 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $372.6 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Procter & Gamble, Colgate-Palmolive Company, Unilever PLC, Sensodyne, Arm & Hammer and Aquafresh among others.
Mexico Chronic Pain Therapeutics Market Analysis
The Mexico Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.115 Bn in 2022 to $1.797 Bn by 2030, with a CAGR of 6.15% during the forecast period of 2022-2030. The key drivers include the escalating risk factors associated with evolving lifestyles and occupational hazards, a shifting preference towards patient-centered care, and ongoing research and development efforts aimed at innovative therapies and precision medicine applications. The Mexico Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Novartis, Merck, GSK, Sanofi, Genomma Lab, Silanes, SOMAR Group, Laboratorios Grin, etc., among various others.
UAE Dental Fluoride Treatment Market Analysis
The UAE Dental Fluoride Treatment Market was valued at $75.8 Mn in 2023 and is projected to grow at a CAGR of 4.9% from 2023 to 2023, to $106 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Julphar Gulf Pharmaceuticals, Dabur International, Colgate, Philips, Dentsply Sirona, VOCO, DÜRRDENTAL among others.
Philippines Chronic Pain Therapeutics Market Analysis
The Philippines Chronic Pain Therapeutics Market is anticipated to experience a growth from $163 Mn in 2022 to $269 Mn by 2030, with a CAGR of 6.4% during the forecast period of 2022-2030. The key drivers include untreated cases due to limited healthcare accessibility and misconceptions, an increasing burden of chronic diseases contributing to a higher demand for pain management solutions, and advancements in healthcare technologies. The Philippines Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AstraZeneca, Sanofi, Merck, Roche, AbbVie, Bayer, Taisho Pharmaceuticals, Unilab, Multicare Pharmaceuticals, etc., among various others.
Brazil Dental Fluoride Treatment Market Analysis
The Brazil Dental Fluoride Treatment Market was valued at $379.2 Mn in 2023 and is projected to grow at a CAGR of 4.9% from 2023 to 2023, to $530 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Fresh Up Italia, Procter & Gamble Company, Fresh, Colgate-Palmolive and Johnson & Johnson among others.
Saudi Arabia Chronic Pain Therapeutics Market Analysis
The Saudi Arabia Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.26 Bn in 2022 to $2.23 Bn by 2030, with a CAGR of 7.4% during the forecast period of 2022-2030. The confluence of certain factors such as the growing healthcare infrastructure, increasing government spending, and rising prevalence of chronic diseases are the key drivers of this market. The Saudi Arabia Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Sanofi, Merck & Co., Tabuk Pharmaceuticals, Hikma Pharmaceuticals, Julphur Pharmaceuticals, etc., among various others.
Mexico Dental Fluoride Treatment Market Analysis
The Mexico Dental Fluoride Treatment Market was valued at $227.5 Mn in 2023 and is projected to grow at a CAGR of 4.15% from 2023 to 2023, to $302.4 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Grupo Grisi, Laboratories Azteca, Colgate, Philips, Dentsply Sirona, VOCO, DÜRRDENTAL among others.
Singapore Chronic Pain Therapeutics Market Analysis
The Singapore Chronic Pain Therapeutics Market is anticipated to experience a growth from $89 Mn in 2022 to $148 Mn by 2030, with a CAGR of 6.5% during the forecast period of 2022-2030. The key drivers influencing the market growth in Singapore include the aging population leading to a surge in chronic conditions, advancements in medicine fuelling innovative pain management solutions, and increased investment in research and development within Singapore's healthcare hub. The Singapore Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AbbVie, Sanofi, Merck, Roche, Mylan, Biocon, Cipla, Dr Reddy’s, Sun Pharma, etc., among various others.
France Dental Fluoride Treatment Market Analysis
The France Dental Fluoride Treatment Market was valued at $417.1 Mn in 2023 and is projected to grow at a CAGR of 2.9% from 2023 to 2023, to $509.5 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Pierre Fabre Oral Care, GUM, Biotech Dental, 3M, Colgate and others.
Germany Dental Fluoride Treatment Market Analysis
The Germany Dental Fluoride Treatment Market was valued at $555.1 Mn in 2023 and is projected to grow at a CAGR of 2.1% from 2023 to 2023, to $642 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Elmex, Meridol, Dr. Best, Dontodent, blend-a-dent Biorepair, Listerine, and Kukident among others.
Spain Chronic Pain Therapeutics Market Analysis
The Spain Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.431 Bn in 2022 to $2.103 Bn by 2030, with a CAGR of 4.9% during the forecast period of 2022-2030. The key drivers include the increasing prevalence of chronic pain conditions due to factors such as an aging population and sedentary lifestyles, coupled with advancements in diagnostic tools and targeted drug delivery systems, as well as collaborations and partnerships. The Spain Chronic Pain Therapeutics Market encompasses various players across different segments, including Sanofi, Pfizer, Merck, Novartis, Bayer, AstraZeneca, Grünenthal, Esteve, Teva, Ferrer, etc., among various others.
Spain Dental Fluoride Treatment Market Analysis
The Spain Dental Fluoride Treatment Market was valued at $292.7 Mn in 2023 and is projected to grow at a CAGR of 2.9% from 2023 to 2023, to $357.6 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Dentaid, Phergal Laboratories, Lacer, Sesderma and Uriach among others.
